List of Excipients in API DAPTOMYCIN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DAPTOMYCIN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Hospira Inc | DAPTOMYCIN | daptomycin | 0409-0122 | ANHYDROUS CITRIC ACID | |
| Hospira Inc | DAPTOMYCIN | daptomycin | 0409-0122 | SODIUM HYDROXIDE | |
| Hospira Inc | DAPTOMYCIN | daptomycin | 0409-5933 | SODIUM HYDROXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DAPTOMYCIN
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 | SODIUM HYDROXIDE |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 | SODIUM HYDROXIDE |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 | SODIUM HYDROXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for DAPTOMYCIN
Excipient focus: ANHYDROUS CITRIC ACID
DAPTOMYCIN drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | daptomycin | 0409-0122 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: ARGININE
DAPTOMYCIN drug variants containing ARGININE
| Company | Ingredient | NDC |
|---|---|---|
| Xellia Pharmaceuticals USA LLC | daptomycin | 70594-066 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing ARGININE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: ARGININE HYDROCHLORIDE
DAPTOMYCIN drug variants containing ARGININE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | daptomycin | 42023-295 |
| MAIA Pharmaceuticals Inc | daptomycin | 70511-181 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing ARGININE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE
DAPTOMYCIN drug variants containing HISTIDINE
| Company | Ingredient | NDC |
|---|---|---|
| Xellia Pharmaceuticals USA LLC | daptomycin | 70594-066 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing HISTIDINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
DAPTOMYCIN drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | daptomycin | 42023-295 |
| Baxter Healthcare Corporation | daptomycin | 60977-145 |
| MAIA Pharmaceuticals Inc | daptomycin | 70511-181 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOLEUCINE
DAPTOMYCIN drug variants containing ISOLEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| Xellia Pharmaceuticals USA LLC | daptomycin | 70594-066 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing ISOLEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
DAPTOMYCIN drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | daptomycin | 60977-145 |
| Bamboo US BidCo LLC | daptomycin | 83703-035 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
DAPTOMYCIN drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Biocon Pharma Inc | daptomycin | 70377-093 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
DAPTOMYCIN drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | daptomycin in sodium chloride | 0338-0712 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
DAPTOMYCIN drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Xellia Pharmaceuticals USA LLC | daptomycin | 70594-066 |
| Baxter Healthcare Corporation | daptomycin in sodium chloride | 0338-0712 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
DAPTOMYCIN drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | daptomycin in sodium chloride | 0338-0712 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
DAPTOMYCIN drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | daptomycin in sodium chloride | 0338-0712 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
DAPTOMYCIN drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | daptomycin | 60977-145 |
| Bamboo US BidCo LLC | daptomycin | 83703-035 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
DAPTOMYCIN drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional LLC | daptomycin | 67457-941 |
| Merck Sharp & Dohme LLC | daptomycin | 67919-012 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
DAPTOMYCIN drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | daptomycin | 69097-850 |
| BE Pharmaceuticals Inc | daptomycin | 71839-108 |
| Baxter Healthcare Corporation | daptomycin in sodium chloride | 0338-0712 |
| >Company | >Ingredient | >NDC |
DAPTOMYCIN drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9378 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9444 |
| Hikma Pharmaceuticals USA Inc | daptomycin | 0143-9465 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
